The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.
Invesco Nasdaq Biotechnology ETF IBBQ
Morningstar’s Analysis IBBQ
Will IBBQ outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 51.6
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Amgen Inc | 8.64 | 2.6 Mil | Healthcare |
Vertex Pharmaceuticals Inc | 8.24 | 2.5 Mil | Healthcare |
Regeneron Pharmaceuticals Inc | 8.14 | 2.5 Mil | Healthcare |
Gilead Sciences Inc | 8.05 | 2.5 Mil | Healthcare |
Moderna Inc | 4.60 | 1.4 Mil | Healthcare |
AstraZeneca PLC ADR | 4.58 | 1.4 Mil | Healthcare |
Biogen Inc | 3.24 | 989,751 | Healthcare |
Illumina Inc | 2.16 | 657,969 | Healthcare |
Alnylam Pharmaceuticals Inc | 2.00 | 611,294 | Healthcare |
Biomarin Pharmaceutical Inc | 1.90 | 580,214 | Healthcare |